Merck EBITDA Margin 2010-2024 | MKKGY

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Merck (MKKGY) over the last 10 years. The current EBITDA margin for Merck as of June 30, 2024 is .
Merck EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-06-30 $22.58B $5.84B 25.85%
2024-03-31 $22.60B $5.85B 25.87%
2023-12-31 $22.72B $5.94B 26.15%
2023-09-30 $22.91B $6.34B 27.65%
2023-06-30 $23.13B $6.45B 27.91%
2023-03-31 $23.27B $6.65B 28.59%
2022-12-31 $23.42B $6.85B 29.26%
2022-09-30 $23.58B $7.01B 29.70%
2022-06-30 $23.60B $7.08B 30.01%
2022-03-31 $23.54B $7.06B 29.98%
2021-12-31 $23.29B $7.03B 30.17%
2021-09-30 $22.79B $6.52B 28.61%
2021-06-30 $22.12B $6.74B 30.46%
2021-03-31 $20.79B $6.13B 29.47%
2020-12-31 $20.03B $5.62B 28.07%
2020-09-30 $19.42B $5.58B 28.74%
2020-06-30 $18.73B $4.81B 25.66%
2020-03-31 $18.66B $4.85B 25.99%
2019-12-31 $18.09B $4.55B 25.16%
2019-09-30 $17.42B $4.34B 24.88%
2019-06-30 $17.27B $4.19B 24.28%
2019-03-31 $17.24B $3.98B 23.10%
2018-12-31 $17.52B $4.18B 23.85%
2018-09-30 $17.87B $4.02B 22.46%
2018-06-30 $17.90B $4.59B 25.63%
2018-03-31 $17.75B $4.72B 26.61%
2017-12-31 $17.32B $4.84B 27.94%
2017-09-30 $16.90B $5.05B 29.85%
2017-06-30 $16.68B $4.66B 27.93%
2017-03-31 $16.70B $4.76B 28.48%
2016-12-31 $16.63B $4.89B 29.40%
2016-09-30 $16.29B $4.75B 29.13%
2016-06-30 $15.63B $4.54B 29.08%
2016-03-31 $14.89B $4.25B 28.54%
2015-12-31 $14.31B $3.78B 26.39%
2015-09-30 $13.91B $3.51B 25.23%
2015-06-30 $14.32B $3.50B 24.42%
2015-03-31 $14.59B $3.52B 24.15%
2014-12-31 $14.78B $3.64B 24.62%
2014-09-30 $15.11B $4.17B 27.62%
2014-06-30 $14.86B $4.42B 29.77%
2014-03-31 $14.80B $4.76B 32.19%
2013-12-31 $14.72B $4.82B 32.72%
2013-09-30 $14.64B $7.31B 49.91%
2013-06-30 $14.55B $6.65B 45.70%
2013-03-31 $14.30B $5.44B 38.02%
2012-12-31 $14.00B $7.60B 54.31%
2012-09-30 $13.66B $7.27B 53.18%
2012-06-30 $13.69B $10.25B 74.86%
2012-03-31 $13.85B $10.32B 74.54%
2011-12-31 $14.08B $10.55B 74.95%
2011-09-30 $14.47B $10.95B 75.64%
2011-06-30 $14.03B $7.98B 56.87%
2011-03-31 $13.05B $10.53B 80.64%
2010-12-31 $12.34B $9.81B 79.52%
2010-09-30 $11.61B $9.09B 78.24%
2010-06-30 $11.25B $11.25B 100.00%
2010-03-31 $11.14B $11.14B 100.00%
2009-12-31 $10.81B $10.81B 100.00%
Sector Industry Market Cap Revenue
Medical MED-DRUGS $21.306B $22.719B
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
Stock Name Country Market Cap PE Ratio
New York Community Bancorp (FLG) United States $4.269B 0.00
Acasti Pharma (GRCE) Canada $0.033B 0.00